ARID1A and ovarian clear cell cancer: TERT promoter mutations, however, tend to be mutually exclusive with loss of ARID1A protein expression in ovarian clear cell carcinoma (OCCC) [46], which suggested that tumours with ARID1A loss may have other mechanisms for the maintenance of telomere lengths.